In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Atthaphon KonyaneeDepartment of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand.ORCID 0009-0006-8108-2168 Habibah A WahabSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden 11800, Pulau Pinang, Malaysia.ORCID 0000-0002-8353-8679 Ezatul Ezleen KamarulzamanSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden 11800, Pulau Pinang, Malaysia.ORCID 0000-0003-0635-1023 Ahmad Marwazi Mohd SuhaimiSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden 11800, Pulau Pinang, Malaysia.
Ahmad Ghazali IsmailSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden 11800, Pulau Pinang, Malaysia.
Prapaporn ChaniadDepartment of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Walaiporn PliratDepartment of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand.ORCID 0000-0003-3782-4807 Arisara PhuwajaroanpongCenter of Excellence in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Thaweesak JuengwatanatrakulFaculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.
Tripetch KanchanapoomFaculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0002-5721-7740 Gorawit YusakulFaculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Chuchard PunsawadDepartment of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand.ORCID 0000-0003-4826-9474 Funding
Walailak University WU68259Walailak University WU-CIA-06407/2025
6 · The paper itselfAbstract
Malaria is a life-threatening global disease, and despite artemisinin-based combination therapies (ACTs) as first-line treatment, emerging drug-resistant
Indexed as
AntimalarialsDrug ResistanceEurycomaPlant ExtractsPlasmodium falciparumComputer SimulationHumansMolecular Docking SimulationMolecular Dynamics SimulationPlant RootsQuassinsAntimalarialseurycomanonePlant ExtractsQuassinsantiplasmodialEurycoma harmandianaEurycoma longifoliamolecular dockingmolecular dynamics simulations
Identifiers
PMID42737792
PMCPMC13566563
What OpenQuestion holds
Textmetadata
Read underepoch 390